Lianshan Zhang
Acadia Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Regulation of Appetite and Obesity, Chemical Synthesis and Analysis, Biochemical Analysis and Sensing Techniques, Microbial Natural Products and Biosynthesis, Diabetes Treatment and Management
Most-Cited Works
- → Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans(2013)661 cited
- → A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents(2014)614 cited
- → A new ligation method for N-terminal tryptophan-containing peptides using the Pictet–Spengler reaction(2000)77 cited
- → pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity(2007)52 cited
- → Solid-Phase Synthesis of C-Terminal Peptide Hydroxamic Acids(2001)20 cited
- → Discovery of a β-MSH-Derived MC-4R Selective Agonist(2005)18 cited
- → Solid-phase synthesis of peptide–heterocycle hybrids containing a tripeptide-derived 6,6-fused bicyclic subunit(2001)15 cited
- → Single-Step Formation of Structurally Defined Bicyclic Peptides via SNAr Cyclization(2001)12 cited
- → Potent and selective MC-4 receptor agonists based on a novel disulfide scaffold(2005)10 cited
- → Potent peptide agonists for human melanocortin 3 and 4 receptors derived from enzymatic cleavages of human β-MSH(5–22) by dipeptidyl peptidase I and dipeptidyl peptidase IV(2005)7 cited